Publications by authors named "Alexander Carlyle"
Article Synopsis
- - The study highlights that quick initiation of biologic therapy is crucial for patients with inflammatory bowel disease (IBD), but various factors can delay this process in an outpatient setting.
- - Researchers analyzed data from 411 patients receiving biologics between March 2019 and September 2020, finding an overall median delay of 20 days, with specific delays varying by medication.
- - Key factors contributing to delays included being self-identified as Black, living farther from treatment facilities, and not having immediate insurance coverage approval.